Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : Previous years symbols : BXRX save search
Delisting of Securities of Sono Group N.V.; Baudax Bio, Inc.; Comera Life Sciences Holdings, Inc.; Missfresh Limited; Rose Hill Acquisition Corporation; Axcella Health; Zivo Bioscience, Inc.; Sonic Foundry, Inc.; Mobiquity Technologies, Inc.; Cuentas, Inc.; micromobility.com Inc.; Harbor Custom Development, Inc.; Nogin, Inc.; Disruptive Acquisition Corporation I; Ebix, Inc.; and Aurora Technology Acquisition Corp. from The Nasdaq Stock Market
Published: 2024-02-13 (Crawled : 21:00) - globenewswire.com
SEVCQ | $0.036 51.57% 20K
|
n/a
|
| O: -7.69%
H: 46.67%
C: 11.83%
CMRA | $0.0595 70.59% 79K
|
n/a
|
| O: 0.0%
H: 0.0%
C: -8.0%
MOBQ | $0.6998 -65.45% 11K
|
|
| O: -14.63%
H: 17.14%
C: 8.57%
NDAQ | $60.03 -0.27% -0.27% 2.8M
|
Finance
|
| O: 0.65%
H: 0.23%
C: -0.45%
nasdaq rose life corporation group acquisition sciences technology market
Baudax Bio Announces Corporate Update
Published: 2023-10-18 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 25.86%
H: 1.16%
C: -18.31%
update
Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors
Published: 2023-09-28 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 87.57%
H: 38.62%
C: -19.67%
ti-168 fda drug granted treatment designation
Baudax Bio to Participate in the H.C. Wainwright Global Investment Conference
Published: 2023-09-07 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 1.04%
H: 2.56%
C: 1.28%
conference global
Baudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
Published: 2023-08-23 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 6.03%
H: 0.0%
C: -4.53%
distribution
Baudax Bio Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Published: 2023-08-17 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -6.11%
H: 5.53%
C: 0.4%
nasdaq direct offering
Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-16 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -3.48%
H: 0.0%
C: 0.0%
business update financial results
Baudax Bio Acquires TeraImmune, Inc.
Published: 2023-06-30 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 23.03%
H: 123.42%
C: 82.81%
Baudax Bio Announces Additional, Positive Top-Line Results From Phase 2 Randomized Clinical Trial of BX1000
Published: 2023-06-07 (Crawled : 13:20) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 7.16%
H: 5.23%
C: -2.57%
bx1000 positive trial results phase 2
Baudax Bio Announces Date of Reconvened Annual Meeting
Published: 2023-06-06 (Crawled : 13:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 1.85%
H: 2.91%
C: 1.8%
meeting
Baudax Bio Reports First Quarter Financial Results and Provides Business Update
Published: 2023-05-12 (Crawled : 12:20) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 2.94%
H: 1.2%
C: -3.14%
business update financial results
Baudax Bio to Present at the Sidoti Virtual Investor Conference
Published: 2023-05-03 (Crawled : 20:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 4.61%
H: 0.0%
C: -1.85%
conference
Baudax Bio Announces Closing of $4 Million Public Offering
Published: 2023-05-01 (Crawled : 22:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 0.31%
H: 1.62%
C: -4.87%
offering
Baudax Bio Announces Pricing of $4 Million Public Offering
Published: 2023-04-27 (Crawled : 02:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -52.0%
H: 7.11%
C: -7.9%
offering
European Midday Briefing: Mood Darkens as Worries -3- – Morningstar
Published: 2023-04-26 (Crawled : 11:00) - spacfeed.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -17.22%
H: 6.94%
C: 2.31%
Melrose Education targets SEN school acquisitions – Business Sale Report
Published: 2023-04-26 (Crawled : 11:00) - spacfeed.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -17.22%
H: 6.94%
C: 2.31%
report acquisitions business education
Self-driving trucks struggle to deliver – Axios
Published: 2023-04-26 (Crawled : 11:00) - spacfeed.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -17.22%
H: 6.94%
C: 2.31%
trucks
CGI reports strong second quarter Fiscal 2023 results – PR Newswire
Published: 2023-04-26 (Crawled : 11:00) - spacfeed.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -17.22%
H: 6.94%
C: 2.31%
results
Trump Is Likely To Face Another Indictment For Interfering in the 2020 Elections as His SPAC Digital World Receives a Non-Compliance Letter From Nasdaq – Wccftech
Published: 2023-04-26 (Crawled : 11:00) - spacfeed.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -17.22%
H: 6.94%
C: 2.31%
nasdaq spac
Baudax Bio Announces Positive Top-Line Final Results From Phase 2 Randomized Clinical Trial of BX1000
Published: 2023-04-25 (Crawled : 13:20) - biospace.com/
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 63.83%
H: 12.66%
C: -32.14%
bx1000 positive trial results phase 2
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.